BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28236326)

  • 1. Human embryonic stem cell-derived hepatoblasts are an optimal lineage stage for hepatitis C virus infection.
    Yan F; Wang Y; Zhang W; Chang M; He Z; Xu J; Shang C; Chen T; Liu J; Wang X; Pei X; Wang Y
    Hepatology; 2017 Sep; 66(3):717-735. PubMed ID: 28236326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
    Schöbel A; Rösch K; Herker E
    Sci Rep; 2018 Mar; 8(1):3893. PubMed ID: 29497123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
    Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
    Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection.
    Xiang Y; Tang JJ; Tao W; Cao X; Song BL; Zhong J
    J Virol; 2015 Jul; 89(13):6805-16. PubMed ID: 25903345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.
    Wu X; Robotham JM; Lee E; Dalton S; Kneteman NM; Gilbert DM; Tang H
    PLoS Pathog; 2012; 8(4):e1002617. PubMed ID: 22496645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro.
    Ke PY; Chen SS
    J Clin Invest; 2011 Jan; 121(1):37-56. PubMed ID: 21135505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model.
    Carpentier A; Tesfaye A; Chu V; Nimgaonkar I; Zhang F; Lee SB; Thorgeirsson SS; Feinstone SM; Liang TJ
    J Clin Invest; 2014 Nov; 124(11):4953-64. PubMed ID: 25295540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating innate immunity improves hepatitis C virus infection and replication in stem cell-derived hepatocytes.
    Zhou X; Sun P; Lucendo-Villarin B; Angus AG; Szkolnicka D; Cameron K; Farnworth SL; Patel AH; Hay DC
    Stem Cell Reports; 2014 Jul; 3(1):204-14. PubMed ID: 25068132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first step towards a mouse model for hepatitis C virus infection containing a human immune system.
    Robinet E; Baumert TF
    J Hepatol; 2011 Sep; 55(3):718-720. PubMed ID: 21616105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response.
    Dash S; Chava S; Aydin Y; Chandra PK; Ferraris P; Chen W; Balart LA; Wu T; Garry RF
    Viruses; 2016 May; 8(5):. PubMed ID: 27223299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells.
    Sakurai F; Kunito T; Takayama K; Hashimoto R; Tachibana M; Sakamoto N; Wakita T; Mizuguchi H
    Virus Res; 2017 Oct; 242():7-15. PubMed ID: 28893653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone.
    Maeda N; Watanabe M; Okamoto S; Kanai T; Yamada T; Hata J; Hozumi N; Katsume A; Nuriya H; Sandhu J; Ishii H; Kohara M; Hibi T
    Liver Int; 2004 Jun; 24(3):259-67. PubMed ID: 15189278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
    Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
    Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.